secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001193125-24-106975
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology raises $1.0M via private placement of 494,096 shares at $2.034/sh and warrants
--------------------------------------------------------------------------------

- Gross proceeds $1.0M from sale of 494,096 shares at $2.034/sh and warrants to purchase same number at $2.26.
- Director Stan Smith purchased 147,492 shares/warrants for ~$300k; Louie Ngar Yee purchased 19,665 for ~$40k.
- Warrants exercisable at $2.26, commencing 6 months from issuance, term 5 years.
- Net proceeds to fund first third of THIO-101 Part C trial for non-small cell lung cancer.
- Closing expected on or about April 25, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524106975/0001193125-24-106975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524106975/d815817d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-106975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer